Recent News

• 06.17.2025 - 2025 BIO International Convention
• 06.11.2025 - Lisata Therapeutics to Present at the 2025 BIO International Convention
• 05.08.2025 - Lisata Therapeutics 1st Quarter 2025 Financial Results and Business Update Conference Call
• 05.08.2025 - Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.01.2025 - Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025
• 04.15.2025 - Lisata Therapeutics Announces Research License with Catalent
• 03.06.2025 - Lisata Therapeutics to Present at the Investival Showcase USA
• 03.05.2025 - Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development
• 02.27.2025 - Full Year 2024 Financial Results and Business Update Conference Call
• 02.27.2025 - Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Recent Filings

• 06.10.2025 - 8-K Current report
• 05.08.2025 - 8-K Current report
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.08.2025 - EX-99.1 EX-99.1
• 04.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.25.2025 - DEF 14A Other definitive proxy statements
• 02.27.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.27.2025 - 8-K Current report